Despesas De Vendas E Administração Alterar Data
Acadia Pharmaceuticals USD 146.88M 1.69M 2026-09
Agios Pharmaceuticals USD 51.55M 13.09M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Immunic USD 3.45M 451K 2025-12
Insmed USD 253.03M 5.56M 2026-09
Ionis Pharmaceuticals USD 154M 23.92M 2026-09
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Kyowa Hakko Kirin JPY 38.91B 4.83B 2026-09
MacroGenics USD 7.9M 1.81M 2026-06
Moderna USD 282M 66M 2026-09
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
PTC Therapeutics USD 80.63M 6.74M 2026-06
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Sarepta Therapeutics USD 118.61M 11.01M 2026-09
Ultragenyx Pharmaceutical USD 97M 9M 2026-09
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09